Evaluation of Pharmacokinetics and Safety Tolerability of Higher Doses of Rifampic

NCT04437836 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Clinical Trial

Interventions

DRUG: Evaluation of high dose rifampicin in children

Sponsor

Kilimanjaro Clinical Research Institute

Collaborators

[object Object]